Artelinic acid

Artelinic acid
Clinical data
ATC code none
Identifiers
CAS Number 120020-26-0 YesY
PubChem (CID) 180423
beta-Artelinic acid: CID 10341948
ChemSpider 8517407 N
ChEMBL CHEMBL477080 N
Chemical and physical data
Formula C23H30O7
Molar mass 418.48 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Artelinic acid (or its salt, artelinate) is an experimental drug that is being investigated as a treatment for malaria.[1] It is a semi-synthetic derivative of the natural compound artemisinin. Artelinic acid has a lower rate of neurotoxicity than the related artemisin derivatives arteether and artemether,[2] but is three times more toxic than artesunate.[3] At present, artelinic acid seems unlikely to enter routine clinical use, because it offers no clear benefits over the artemesinins already available (artesunate and artemether). Artelinic acid has not yet been evaluated for use in humans.

References

  1. Bustos MD, Gay F, Diquet B (1994). "In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives.". Bull World Health Org. 72: 729–35.
  2. Genovese RF, Newman DB, Brewer TG (2000). "Behavioural and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats". Pharmacol Biochem Behav. 67 (1): 37–44. doi:10.1016/S0091-3057(00)00309-9. PMID 11113482.
  3. Li Q, Xie LH, Johnson TO, et al. (2007). "Toxicity exaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats". Trans R Soc Trop Med Hyg Z. 101 (2): 104–12. doi:10.1016/j.trstmh.2006.04.010. PMID 16860356.
This article is issued from Wikipedia - version of the 5/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.